| DANVERS,
Mass. (May 13, 2005) - ABIOMED, Inc. (NASDAQ: ABMD) a manufacturer
of products for circulatory care and support, today announced that
Michael R. Minogue, Chief Executive Officer and President, is scheduled
to present at the Banc of America Securities 2005 Health Care Conference.
The conference is being held from May 17-19, 2005 at the Four Seasons
Hotel in Las Vegas. Mr. Minogue is scheduled to present on Thursday,
May 19th at 12:00 p.m., Pacific Time (3:00 p.m., Eastern Time).
Mr. Minogue’s presentation will also be available live via
a webcast that can be accessed through the Company’s website:
www.abiomed.com.
About ABIOMED
Based in Danvers, Massachusetts, ABIOMED, Inc. (pronounced “AB’-EE-O-MED”)
is a leading developer, manufacturer and marketer of medical products
designed to assist or replace the pumping function of the failing
heart. ABIOMED, which currently sells the BVS® 5000 Biventricular
Support System and the AB5000™ Circulatory Support System,
is the market leader in devices for the temporary support of patients
with failing but potentially recoverable hearts. ABIOMED is also
pursuing initial FDA market approval for the AbioCor® Implantable
Replacement Heart under a Humanitarian Device Exemption to treat
a defined subset of irreversible end-stage heart failure patients.
For additional information about ABIOMED, please visit www.abiomed.com.
###
Media Contact:
Communications Specialist
(978) 646-1419
mediarelations@abiomed.com
Investor Relations Contact:
Jane Petrino
Noonan Russi
(212) 845-4274 jane.petrino@eurorscg.com
|